Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. BeiGene Ltd. ADR shares valued at $14,131,339 were purchased by XIAOBIN WU on Apr 01 ’25. At $272.17 per share, XIAOBIN WU acquired 51,921 shares.
Also, Wang Xiaodong sold 41,760 shares, netting a total of over 10,911,252 in proceeds. Following the sale of shares at $261.28 each, the insider now holds 0 shares.
Before that, OYLER JOHN had sold 41,210 shares from its account. In a trade valued at $10,000,483, the Chief Executive Officer traded BeiGene Ltd. ADR shares for $242.67 each. Upon closing the transaction, the insider’s holdings decreased to 41,210 shares, worth approximately $0.0.
As published in a research note from BofA Securities on March 03, 2025, BeiGene Ltd. ADR [ONC] has been rated up from a Neutral to a Buy and the price target has been revised to $320 from $207. As of September 18, 2024, JMP Securities has initiated its “Mkt outperform” rating for ONC.
Analyzing ONC Stock Performance
During the last five days, there has been a surge of approximately 9.51%. Over the course of the year, BeiGene Ltd. ADR shares have jumped approximately 48.76%. Shares of the company reached a 52-week high of $287.88 on 02/27/25 and a 52-week low of $172.67 on 01/08/25. A 50-day SMA is recorded $245.53, while a 200-day SMA reached $203.49.
Support And Resistance Levels for BeiGene Ltd. ADR (ONC)
According to the 24-hour chart, there is a support level at 270.57, which, if violated, would cause prices to drop to 266.35. In the upper region, resistance lies at 277.50. The next price resistance is at 280.21. RSI (Relative Strength Index) is 64.19 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 10.59, which suggests the price will increase in the coming days. Percent R is at 26.68%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
